Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 456 clinical trials
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer (IMpassion132)

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer

capecitabine
triple negative breast cancer
measurable disease
anthracyclines
triple-negative breast cancer
  • 296 views
  • 12 Jul, 2022
  • 74 locations
A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

neoadjuvant therapy in participants with triple negative breast cancer (TNBC). Participants will be randomized in a 1:1 ratio to Arm A (camrelizumab +chemotherapy) or Arm B (placebo + chemotherapy).

erbb2
triple negative breast cancer
HER2
  • 0 views
  • 21 Mar, 2022
  • 1 location
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer (TCTN)

(EC-TCb) in triple-negative breast cancer.

triple negative breast cancer
lobular carcinoma
docetaxel
estrogen
immunohistochemistry
  • 90 views
  • 24 Apr, 2022
  • 26 locations
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment (TORCHLIGHT)

first/second line treatment of metastatic or recurrent triple-negative breast cancer (TNBC).

triple negative breast cancer
measurable disease
estrogen
paclitaxel
mammogram
  • 48 views
  • 10 May, 2022
  • 68 locations
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer (Morpheus-TNBC)

1 (PD-L1)-positive participants who have received no prior systemic therapy for metastatic or inoperable locally advanced triple-negative breast cancer (TNBC) (first-line [1L] PD-L1+ cohort), and

capecitabine
measurable disease
paclitaxel
triple-negative breast cancer
cancer
  • 309 views
  • 27 Jul, 2022
  • 28 locations
A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib Carelizumab Plus Nab-paclitaxel and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

and Apatinib, carelizumab plus nab-paclitaxel, and Nab-paclitaxel in Patients with Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer. Participants will be randomized in a 1:1:1

locally advanced breast cancer
triple negative breast cancer
measurable disease
paclitaxel
triple-negative breast cancer
  • 11 views
  • 24 Jan, 2021
  • 1 location
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer (PANSY)

docetaxel (EC4-T4) verses 6 cycles of weekly paclitaxel combined with carboplatin (PCb*6) in the adjuvant chemotherapy of non-triple negative breast cancer patients. The study is divided in to 2

triple negative breast cancer
docetaxel
metastasis
trastuzumab
invasive breast cancer
  • 11 views
  • 20 Feb, 2022
  • 1 location
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Triple-negative breast cancer (TNBC) accounts for about 20% of clinical breast cancer. Clinical characteristics include early onset, high malignancy and heterogeneity. There is no effective drug

growth factor
metastasis
estrogen
progesterone
paclitaxel
  • 0 views
  • 31 Jul, 2021
  • 1 location
  • 397 views
  • 11 Aug, 2022
  • 413 locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

alone or paclitaxel and carboplatin in treating triple-negative breast cancer.

metastasis
absolute neutrophil count
renal function
lobular carcinoma in situ
adenocarcinoma
  • 1025 views
  • 17 May, 2022
  • 789 locations